Weekly Digest – July 2025 Weekly Digest – July 2025 03 July 2025: Akeso’s first bispecific ADC (Trop2/Nectin4 ADC) enters clinical trials, strengthening leadership in ‘IO+ADC’ 2.0 strategy Akeso has dosed the first patient in the Phase 1 clinical trial […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id